World's Best Scientists 2026 revealed!
Andreas E. Kulozik

Andreas E. Kulozik

Award Badge
Genetics
Germany
2024

D-Index & Metrics

Medicine

D-Index
92
Citations
41494
World Ranking
11121
National Ranking
604

Genetics

D-Index
90
Citations
39918
World Ranking
1063
National Ranking
88

Andreas E. Kulozik publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Andreas E. Kulozik sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 340 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Andreas E. Kulozik D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Andreas E. Kulozik sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 90 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2024 - Research.com Genetics in Germany Leader Award
  • 2023 - Research.com Genetics in Germany Leader Award
  • 2011 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Human Genetics and Molecular Medicine
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Andreas E. Kulozik is affiliated with Heidelberg University in Germany. Their research spans several fields with a focus on genetics, molecular biology, hematology, public health, environmental and occupational health, and oncology. The primary areas of study include hemoglobinopathies and related disorders, acute lymphoblastic leukemia research, iron metabolism and disorders, CAR-T cell therapy, sarcoma diagnosis and treatment, neonatal health and biochemistry, and immune cell function and interaction.

Their scholarly output includes significant contributions published in renowned journals such as Blood, Transplantation and Cellular Therapy, HemaSphere, bioRxiv (Cold Spring Harbor Laboratory), and Nature Communications. These venues reflect the scope and interdisciplinary nature of their work.

Recent papers authored or coauthored by Andreas E. Kulozik include:

  • "Sarcoma classification by DNA methylation profiling," 2021, Nature Communications
  • "The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets," 2021, Cancer Discovery
  • "Recommendations for diagnosis and treatment of methemoglobinemia," 2021, American Journal of Hematology
  • "The evaluation of iron deficiency and iron overload," 2021, Deutsches Ärzteblatt international
  • "2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations," 2020, Nature Communications

Frequent coauthors working alongside Andreas E. Kulozik include:

  • Joachim B. Kunz
  • Mark C. Walters
  • Suradej Hongeng
  • Martin G. Sauer
  • Adrian J. Thrasher

Their research topics cover a broad spectrum within molecular medicine and clinical hematology, specifically focusing on:

  • Hemoglobinopathies and Related Disorders
  • Acute Lymphoblastic Leukemia research
  • Iron Metabolism and Disorders
  • CAR-T cell therapy research
  • Sarcoma Diagnosis and Treatment
  • Neonatal Health and Biochemistry
  • Immune Cell Function and Interaction

Throughout their career, Andreas E. Kulozik has been recognized by scientific organizations, including the German National Academy of Sciences Leopoldina, where they were inducted in 2011 with a citation in Human Genetics and Molecular Medicine. They are also a member of the European Molecular Biology Organization (EMBO).

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones

  • Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

    Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

    Kristian W. Pajtler;Kristian W. Pajtler;Hendrik Witt;Martin Sill;David T.W. Jones

  • A perfect message : RNA surveillance and nonsense-mediated decay

    Matthias W Hentze;Andreas E Kulozik

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

    Tobias Rausch;David T.W. Jones;Marc Zapatka;Adrian M. Stütz

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Nonsense-mediated decay approaches the clinic

    Jill A Holbrook;Gabriele Neu-Yilik;Gabriele Neu-Yilik;Matthias W Hentze;Andreas E Kulozik;Andreas E Kulozik

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Paul A. Northcott;Catherine Lee;Catherine Lee;Thomas Zichner;Adrian M. Stütz

  • Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

    S. C. Mack;H. Witt;R. M. Piro;L. Gu

  • A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA).

    Mirco Castoldi;Sabine Schmidt;Vladimir Benes;Mikkel Noerholm

  • Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

    Hendrik Witt;Stephen C. Mack;Marina Ryzhova;Sebastian Bender;Sebastian Bender

  • BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

    Stefan Pfister;Wibke G. Janzarik;Marc Remke;Aurélie Ernst

  • Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

    Pascal D. Johann;Pascal D. Johann;Serap Erkek;Marc Zapatka;Kornelius Kerl

  • BINARY SPECIFICATION OF NONSENSE CODONS BY SPLICING AND CYTOPLASMIC TRANSLATION

    Rolf Thermann;Gabriele Neu‐Yilik;Andrea Deters;Ute Frede

  • Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

    Chen Shochat;Noa Tal;Noa Tal;Obul R. Bandapalli;Obul R. Bandapalli;Chiara Palmi

  • 3′ end mRNA processing: molecular mechanisms and implications for health and disease

    Sven Danckwardt;Matthias W Hentze;Andreas E Kulozik;Andreas E Kulozik

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Matthias W. Hentze
Matthias W. Hentze European Molecular Biology Laboratory
Andreas von Deimling
Andreas von Deimling Heidelberg University
Martina U. Muckenthaler
Martina U. Muckenthaler Heidelberg University
Peter Lichter
Peter Lichter German Cancer Research Center
Marc Remke
Marc Remke German Cancer Research Center
Jan O. Korbel
Jan O. Korbel European Molecular Biology Laboratory
David T. W. Jones
David T. W. Jones German Cancer Research Center
Martin Schrappe
Martin Schrappe Kiel University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Genetics is a foundation for numerous careers in health and science. As the demand for healthcare professionals grows, many students are considering flexible online programs to expand their expertise and job prospects. For example, pursuing one of the affordable fnp programs is a smart option for those interested in advanced practice roles with a genetics background.

Nursing continues to be a leading career path, and many students start by seeking out cheap nursing programs to minimize debt. Those already in the field can further their credentials with the dnp programs that focus on leadership, research, and advanced clinical skills.

Additionally, for registered nurses aiming to strengthen their genetics expertise or move into specialized roles, the cheapest online bsn programs offer an accessible route to higher qualifications. These related degrees all provide a flexible, affordable way to further your career while integrating valuable genetics knowledge.

Best Scientists Citing Andreas E. Kulozik

Trending Scientists

Recently Published Articles